Midatech Pharma Plc RSI
Qual é o RSI de Midatech Pharma Plc?
O RSI de Midatech Pharma Plc é 15.33
Qual é a definição de RSI?
O índice de força relativa (RSI 14) é um indicador de momento que compara a magnitude de ganhos e perdas em um período de tempo especificado para medir a velocidade e a variação dos movimentos de preço de um título.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI de empresas na Setor Health Care em LSE em comparação com Midatech Pharma Plc
O que Midatech Pharma Plc faz?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Empresas com rsi semelhantes a Midatech Pharma Plc
- Sonasoft tem RSI de 15.26
- Therapeutics Acquisition Corp tem RSI de 15.27
- Vital Mobile tem RSI de 15.28
- China National Culture tem RSI de 15.29
- China Everbright tem RSI de 15.30
- OBJ tem RSI de 15.30
- Midatech Pharma Plc tem RSI de 15.33
- Bank of Gansu Co tem RSI de 15.34
- Advance Auto Parts tem RSI de 15.37
- Pason Systems tem RSI de 15.37
- The Conygar Investment PLC tem RSI de 15.40
- Future Data tem RSI de 15.41
- Score Media and Gaming tem RSI de 15.44